Search research articles
Contact Us
Filters
Showing results (1-10 of 238) with videos related to
Page
of 24
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
April 29, 2021
Development and evaluation of a physiologically based pharmacokinetic model to predict carvedilol-paroxetine metabolic drug-drug interaction in healthy adults and its extrapolation to virtual chronic heart failure patients for dose optimization
Muhammad Fawad Rasool, Stephanie Läer
Journal of Global Health
|
October 18, 2024
Climate-responsive telemedicine: Innovative strategy for enhancing healthcare in the face of climate change
Muhammad Fawad, Saif Ullah, Xiaolin Xu
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 13, 2016
Predicting Stereoselective Disposition of Carvedilol in Adult and Pediatric Chronic Heart Failure Patients by Incorporating Pathophysiological Changes in Organ Blood Flows-A Physiologically Based Pharmacokinetic Approach
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
JPMA. the Journal of the Pakistan Medical Association
|
July 20, 2023
The impact of cognitive impairment resulting from traumatic brain injury on health-related quality of life (HRQOL) in Pakistan
Ahmad Danial, Laveeza Fatima, Muhammad Fawad Bosan
Clinical Pharmacokinetics
|
March 17, 2015
A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
Expert Opinion on Drug Metabolism & Toxicology
|
January 25, 2024
Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing models
Ammara Zamir, Faleh Alqahtani, Muhammad Fawad Rasool
Clinical Pharmacokinetics
|
December 10, 2015
Author's Reply to Zheng et al.: A Physiologically Based Pharmacokinetic Drug-Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood Flows
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
European Journal of Drug Metabolism and Pharmacokinetics
|
June 18, 2016
Optimizing the Clinical Use of Carvedilol in Liver Cirrhosis Using a Physiologically Based Pharmacokinetic Modeling Approach
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
Frontiers in Oncology
|
October 31, 2022
A framework for identification and classification of liver diseases based on machine learning algorithms
Huanfei Ding, Muhammad Fawad, Xiaolin Xu, et al.
Healthcare (Basel, Switzerland)
|
September 28, 2024
The Economic Burden of Type 2 Diabetes Mellitus in Pakistan: A Cost of Illness Study
Muhammad Subhan Arshad, Faleh Alqahtani, Muhammad Fawad Rasool
Page
of 24
Search research articles
Search
Showing results (1-10 of 238) with videos related to
Sort By:
Page
of 24
Expert Opinion on Drug Metabolism & Toxicology
|
April 29, 2021
Development and evaluation of a physiologically based pharmacokinetic model to predict carvedilol-paroxetine metabolic drug-drug interaction in healthy adults and its extrapolation to virtual chronic heart failure patients for dose optimization
Muhammad Fawad Rasool, Stephanie Läer
Journal of Global Health
|
October 18, 2024
Climate-responsive telemedicine: Innovative strategy for enhancing healthcare in the face of climate change
Muhammad Fawad, Saif Ullah, Xiaolin Xu
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 13, 2016
Predicting Stereoselective Disposition of Carvedilol in Adult and Pediatric Chronic Heart Failure Patients by Incorporating Pathophysiological Changes in Organ Blood Flows-A Physiologically Based Pharmacokinetic Approach
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
JPMA. the Journal of the Pakistan Medical Association
|
July 20, 2023
The impact of cognitive impairment resulting from traumatic brain injury on health-related quality of life (HRQOL) in Pakistan
Ahmad Danial, Laveeza Fatima, Muhammad Fawad Bosan
Clinical Pharmacokinetics
|
March 17, 2015
A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
Expert Opinion on Drug Metabolism & Toxicology
|
January 25, 2024
Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing models
Ammara Zamir, Faleh Alqahtani, Muhammad Fawad Rasool
Clinical Pharmacokinetics
|
December 10, 2015
Author's Reply to Zheng et al.: A Physiologically Based Pharmacokinetic Drug-Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood Flows
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
European Journal of Drug Metabolism and Pharmacokinetics
|
June 18, 2016
Optimizing the Clinical Use of Carvedilol in Liver Cirrhosis Using a Physiologically Based Pharmacokinetic Modeling Approach
Muhammad Fawad Rasool, Feras Khalil, Stephanie Läer
Frontiers in Oncology
|
October 31, 2022
A framework for identification and classification of liver diseases based on machine learning algorithms
Huanfei Ding, Muhammad Fawad, Xiaolin Xu, et al.
Healthcare (Basel, Switzerland)
|
September 28, 2024
The Economic Burden of Type 2 Diabetes Mellitus in Pakistan: A Cost of Illness Study
Muhammad Subhan Arshad, Faleh Alqahtani, Muhammad Fawad Rasool
Page
of 24